Skip to content
10-K

Annual Report

TENAX THERAPEUTICS, INC. TENX

0000950170-25-044398

← back to feed
Filed
Mar 25, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 21, 2025 3.97M sh
Revenue FY 2024 · Dec 31, 2024 $0
Shares Diluted FY 2024 · Dec 31, 2023 248.45K sh
Operating Cash Flow restated FY 2024 · Dec 31, 2023 −$5.9M
Cash And Equivalents FY 2024 · Dec 31, 2023 $9.8M
Current Liabilities restated FY 2024 · Dec 31, 2023 $3.59M
Total Liabilities restated FY 2024 · Dec 31, 2023 $3.59M
Current Assets restated FY 2024 · Dec 31, 2023 $11.68M
Total Assets restated FY 2024 · Dec 31, 2023 $11.69M
Eps Diluted FY 2024 · Dec 31, 2023 −$31.04
Eps Basic FY 2024 · Dec 31, 2023 −$31.04
Rd Expense restated FY 2024 · Dec 31, 2023 $3.23M
Net Income restated FY 2024 · Dec 31, 2023 −$7.71M
Operating Income restated FY 2024 · Dec 31, 2023 −$8.23M
Stockholders Equity restated FY 2024 · Dec 31, 2022 $1.49M